Konstantinos Syrigos to Prognosis
This is a "connection" page, showing publications Konstantinos Syrigos has written about Prognosis.
Connection Strength
0.161
-
Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc Med. 2021 08; 26(4):415-425.
Score: 0.042
-
Cardiac injury and prognosis in COVID-19: Methodological considerations and updated meta-analysis. J Infect. 2020 08; 81(2):e181-e182.
Score: 0.040
-
Circulating tumor cells count as a predictor of survival in lung cancer. Crit Rev Oncol Hematol. 2018 May; 125:60-68.
Score: 0.034
-
A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer. Lung Cancer. 2019 10; 136:52-56.
Score: 0.009
-
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis. Clin Cancer Res. 2019 08 01; 25(15):4663-4673.
Score: 0.009
-
Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations. J Thorac Oncol. 2018 12; 13(12):1884-1896.
Score: 0.009
-
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Clin Cancer Res. 2017 Sep 01; 23(17):5202-5209.
Score: 0.008
-
Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest. 2014 Jan; 94(1):107-16.
Score: 0.006
-
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma. Clin Cancer Res. 2009 Jun 15; 15(12):4157-64.
Score: 0.005